COUNTERPOINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? No

Editorial

Open access

David Jimenez, Parth Rali and Kevin Doerschug

Chest, Vol.161(6), pp.1448-1451

03/15/2022

DOI: 10.1016/j.chest.2022.01.037

PMCID: PMC8923523

PMID: 35550714

Files and links (1)

url

https://doi.org/10.1016/j.chest.2022.01.037View

Published (Version of record) Open Access

Point and Counterpoint

Title: Subtitle: COUNTERPOINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? No
Creators: David Jimenez - Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
Parth Rali - Temple University
Kevin Doerschug - University of Iowa
Resource Type: Editorial
Publication Details: Chest, Vol.161(6), pp.1448-1451
DOI: 10.1016/j.chest.2022.01.037
PMID: 35550714
PMCID: PMC8923523
NLM abbreviation: Chest
ISSN: 0012-3692
eISSN: 1931-3543
Publisher: Published by Elsevier Inc under license from the American College of Chest Physicians
Language: English
Date published: 03/15/2022
Academic Unit: Pulmonary, Critical Care, and Occupational Medicine; Internal Medicine
Record Identifier: 9984359793102771

14 Record Views